Literature DB >> 25912601

High false-positive rate of questionnaire-based restless legs syndrome diagnosis in multiple sclerosis.

V Mery1, R J Kimoff1, I Suarez1, A Benedetti2, M Kaminska3, A Robinson4, Y Lapierre4, A Bar-Or4, D A Trojan5.   

Abstract

BACKGROUND/
OBJECTIVES: Restless legs syndrome (RLS) is diagnosed by self-reported symptoms. Multiple sclerosis (MS) patients have disease-related symptoms which could mimic RLS. This study assessed the: (1) false-positive rate for questionnaire-based RLS diagnosis in MS patients and (2) utility of periodic leg movements during wakefulness (PLMW) on overnight polysomnography (PSG) in identifying true-positive RLS patients.
METHODS: Ambulatory MS patients without known sleep disorders were recruited. Subjects completed the International RLS Study Group (IRLSG) diagnostic questionnaire (IRLDQ) and underwent full overnight PSG. IRLDQ-positive patients underwent clinical evaluation to confirm the diagnosis and completed the RLS severity scale (IRLS).
RESULTS: Seventy-one MS patients (mean age 46.8 ± 10.4 years) were evaluated. Thirty-eight had a positive IRLDQ. RLS diagnosis was confirmed in 22, yielding a false-positive rate of 42% [95% confidence interval (CI) 26-59%], predominantly attributable to paresthesiae (n = 7), and cramps and/or muscle spasms (n = 4). IRLS scores were not significantly different between subjects with confirmed and nonconfirmed RLS. The PLMW index was significantly higher in patients with confirmed RLS (55.4 ± 41.9 vs. 29.7 ± 18.8, p = 0.03). The sensitivity of a PLMW index >70/h for true-positive IRLDQ was 8/22 = 36%, 95% CI: 17.2-59.3, and the specificity was 16/16 = 100%, 95% CI: 79.4-100.
CONCLUSIONS: MS patients have a high false-positive rate of RLS diagnosis using a standardized questionnaire largely attributable to MS-related sensorimotor symptoms. While detailed clinical evaluation is essential for confirming RLS diagnosis, the PLMW index may provide useful adjunctive information.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  International Restless Legs Syndrome Study Group questionnaire; Multiple sclerosis; Periodic leg movements; Polysomnography; Restless legs syndrome

Mesh:

Year:  2015        PMID: 25912601     DOI: 10.1016/j.sleep.2015.02.529

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  7 in total

1.  [Frequent neurological diseases associated with the restless legs syndrome].

Authors:  M Bartl; J Winkelmann; B Högl; W Paulus; C Trenkwalder
Journal:  Nervenarzt       Date:  2018-10       Impact factor: 1.214

2.  Restless leg syndrome and multiple sclerosis: a case-control study in China.

Authors:  Gangqiong Liu; Xiao Feng; Chao Lan; Ziqiang Zhu; Shengli Ma; Yu Guo; Rui Xue
Journal:  Sleep Breath       Date:  2015-05-24       Impact factor: 2.816

Review 3.  The prevalence of restless legs syndrome (RLS) in patients with multiple sclerosis (MS): a systematic review and meta-analysis-an update.

Authors:  Alireza Zali; Mahsa Motavaf; Saeid Safari; Narges Ebrahimi; Mahsa Ghajarzadeh; Reza Jalili Khoshnood; Omid Mirmosayyeb
Journal:  Neurol Sci       Date:  2022-09-05       Impact factor: 3.830

4.  Impact, Frequency, and Severity of Restless Legs Syndrome in Patients with Multiple Sclerosis in Argentina.

Authors:  Edgar Carnero Contentti; Pablo A López; Debora Nadur; María Eugenia Balbuena; Ana Mariel Finkelstein; Verónica Tkachuk
Journal:  Int J MS Care       Date:  2019 Jul-Aug

5.  The Neurological Sleep Index: A suite of new sleep scales for multiple sclerosis.

Authors:  R J Mills; A Tennant; C A Young
Journal:  Mult Scler J Exp Transl Clin       Date:  2016-04-07

6.  Restless Legs Syndrome in Multiple Sclerosis.

Authors:  Taşkın Güneş; Ufuk Emre; Yüksel Erdal; Osman Özgür Yalin
Journal:  Noro Psikiyatr Ars       Date:  2019-08-16       Impact factor: 1.339

7.  Validity and reliability of the suggested immobilization test for measurement of restless legs syndrome severity in adults with multiple sclerosis.

Authors:  Katie L J Cederberg; Arthur S Walters; Amy W Amara; Tiffany J Braley; Morgan L Schuetz; Brianna G Mathison; Robert W Motl
Journal:  Sleep Med       Date:  2021-06-16       Impact factor: 4.842

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.